Here's why the Avita Medical share price is tumbling 20% today

Shares in the healthcare company are tanking today, despite no fresh news out since last week.

| More on:
A man sits uncomfortably at his laptop computer in an outdoor location at a table with trees in the background as he clutches the back of his neck with a wincing look on his face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Avita Medical shares have copped a pounding today, down close to 20%
  • The dual-listed company released an update last Friday, but ASX investors seemed to be far more forgiving back then
  • It seems ASX investors might be following Avita's less-forgiving US investors today

It's been a fairly lacklustre start to the trading week for most ASX shares so far this Monday. At the time of writing, the All Ordinaries Index (ASX: XAO) has fallen by 0.21%. But let's talk about the plunging Avita Medical Inc. (ASX: AVH) share price.

Avita Medical shares are in freefall today. This ASX healthcare share has dropped by a precipitous 19.38% so far this Monday to $3.66 a share. That comes after Avita shares closed at $4.54 each last Friday.

It was even worse for Avita this morning too, with the shares hitting a low of $3.53 soon after market open. That was a drop of 22.25% at the time.

So what on earth is going on with Avita shares today that has this company losing so much value?

Why has the Avita Medical share price lost 20% today?

Well, Avita is a bit of a unique case on the ASX. The company is actually a dual-listed share, with its other listing being on the United States NASDAQ exchange – Avita Medical Inc. (NASDAQ: RCEL).

Last Friday, Avita released some financial results and guidance to investors, covering the three months to 31 March 2023. These results revealed a 40% increase in revenue for the quarter to $10.6 million, as well as a rise in gross profit margins to 84%.

The company also announced a major change in its leadership team. Chief commercial officer Erin Liberto has resigned from the company, while Terry Bromley and Debbie Gardener have been promoted to senior vice president of global sales, and senior vice president of global marketing and strategy respectively.

ASX investors reacted negatively to this news on Friday's session, sending Avita shares down by 5.42%.

But Avita's American investors were far more savage on Friday night (our time). Over on the NASDAQ, the Avita share price tanked by a nasty 22.94%.

It seems Avita's ASX investors might be taking a lead from their American counterparts today in the wake of Friday's far more savage reaction. This could explain the doubling down of selling pressure that we seem to be witnessing on the ASX today.

But shareholders arguably don't have too much to complain about. Even after today's savage selling, the Avita share price on the ASX is still up a whopping 90% in 2023 so far:

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 113% in a year, guess which ASX 200 healthcare stock just scored another FDA win

The ASX 200 healthcare stock received another FDA approval for its cancer detection product.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Telix shares slip 11% from highs. Time to buy this high flying biotech?

Is now the time to look at the biotech flyer?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Up 200% in a year! Why is this ASX healthcare stock rocketing today?

This stock just can't stop rising. What is it this time?

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Earnings Results

Sigma shares climb after reporting massive 878% profit jump for FY25

Big profits have been reported from this pharmacy chain giant this morning.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 13%! Check out the latest ASX stock to receive FDA approval

Big news is giving this stock a lift on Thursday. Here's what is happening.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Healthcare Shares

Guess which ASX stock is surging 11% on big US FDA news

Big news is lifting this stock higher on Wednesday. Let's find out what's happening.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Bell Potter says this ASX 200 share can rise 120%

Let's see what the broker is saying about this beaten down stock.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Why is this ASX 200 healthcare share leaping 14% today?

Clarity Pharmaceuticals is the biggest gainer of the ASX 200 on Tuesday.

Read more »